Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ahmed Elzoghby, Ph.D.

Title
Institution
Department
Address
Profile Picture

Biography
Brigham and Women's HospitalPostdoc Fellow07/2022Biomedical Engineering (Immunoengineering)
Cancer Nanotechnology Research Laboratory (CNRL) Director12/2017Pharmaceutical Sciences (Drug Delivery)
Faculty of Pharmacy, Alexandria University Ph.D.10/2012Pharmaceutical Sciences (Drug Delivery)
Faculty of Pharmacy, Alexandria UniversityM.Sc.09/2009Pharmaceutical Sciences (Drug Delivery)
Faculty of Pharmacy, Alexandria UniversityB.Sc.06/2003Pharmaceutical Sciences
2018
Fulbright Visiting Scholar Award
2021
Highly Cited Researcher Award
2022
Highly Cited Researcher Award
2022
BRIght Futures Prize Award
2023
Highly Cited Researcher Award
2024
Litwin IBD Pioneers Award
2024
Department of Defense Concept Award
2024
Joslin DRC Pilot & Feasibility Award
2025
Department of Defense Discovery Award

Overview
My research focuses on immunoengineering of tumor microenvironment (TME) to overcome the resistance to cancer immunotherapy. More particularly, I am engineering innovative nanomedicines to disrupt the vicious crosstalk between cancer cells and stromal cancer associated fibroblasts (CAFs) via modulating the release and cargo of tumoral and stromal exosomes.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. PR240001 (Ahmed Elzoghby) Jan 1, 2025 - Dec 31, 2026
    Department of Defense office of the Congressionally Directed Medical Research Programs (CDMRP)
    Highly Penetrating Nanodisc for Targeting Fibroblast Plasticity in Pulmonary Fibrosis
    Role: Principal Investigator
  2. 2023A072971 (Ahmed Elzoghby) May 1, 2024
    Joslin DRC Pilot & Feasibility Program, Joslin Diabetes Center
    Halting Diabetic Renal Fibrosis Progression using Bimodal Circularized Nanodisc
    Role: Principal Investigator
  3. 1158589 (Ahmed Elzoghby) Jan 1, 2024 - Dec 31, 2024
    Litwin IBD Pioneers Program, Crohn's & Colitis Foundation
    Engineered nanomedicine for reversal of fibrosis in Crohn's disease patients
    Role: Principal Investigator
  4. KC230061 (Ahmed Elzoghby) Jan 1, 2024 - Dec 31, 2024
    Department of Defense office of the Congressionally Directed Medical Research Programs (CDMRP)
    Engineering AntagomiR Nanodiscs to Reprogram Renal Cell Carcinoma-Associated Fibroblasts
    Role: Principal Investigator
  5. 2022A015398 (Ahmed Elzoghby) Nov 1, 2022 - Oct 31, 2024
    BRIght Futures Prize 2022, Brigham Research Institute (BRI)
    Genetically Engineered Fibroblasts as In Situ Factory of Cytolytic Exosomes
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Elzoghby's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (241)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.